Graphite Bio, Inc. - stock earnings
GRPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -22.9 million USD | 10.2 million USD |
| 2023Q3 | -22.5 million USD | ? USD |
| 2023Q2 | -55.3 million USD | ? USD |
| 2023Q1 | -21.4 million USD | ? USD |
| 2022Q4 | -22.4 million USD | ? USD |
| 2022Q3 | -23.2 million USD | ? USD |
| 2022Q2 | -25.1 million USD | ? USD |
| 2022Q1 | -25.7 million USD | ? USD |
| 2021Q4 | -18.9 million USD | ? USD |
| 2021Q3 | -14.6 million USD | ? USD |
| 2021Q2 | -17.5 million USD | ? USD |
| 2021Q1 | -19.7 million USD | ? USD |
| 2020Q4 | -63.5 million USD | ? USD |
| 2020Q3 | -3.4 million USD | ? USD |
| 2020Q2 | -1.3 million USD | ? USD |
| 2020Q1 | -141000 USD | ? USD |
GRPH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -124.7 million USD | ? USD |
| 2022 | -96.5 million USD | ? USD |
| 2021 | -59.7 million USD | ? USD |
| 2020 | -13.6 million USD | ? USD |
| 2019 | -189000 USD | ? USD |
GRPH
Price: $3.18
52 week price:
Earnings Per Share: -2.23 USD
P/E Ratio: -1.37
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 124104
Market Capitalization: 189.8 million